Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2022011005 - IMMUNOSTIMULATORY ADJUVANTS

Publication Number WO/2022/011005
Publication Date 13.01.2022
International Application No. PCT/US2021/040676
International Filing Date 07.07.2021
IPC
A61K 39/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
A61K 39/39 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
39characterised by the immunostimulating additives, e.g. chemical adjuvants
A61P 31/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • ORIONIS BIOSCIENCES, INC. [US]/[US]
  • VIB VZW [BE]/[BE]
  • UNIVERSITEIT GENT [BE]/[BE]
Inventors
  • KLEY, Nikolai
  • TAVERNIER, Jan
  • PEELMAN, Frank
  • GERLO, Sarah
  • VAN DEN EECKHOUT, Bram
Agents
  • ALTIERI, Stephen, L.
  • CURRIE, Matthew, T.
  • FRANK, Steven, J.
  • HAYMAN, Mark, L.
  • BATES, Emily
Priority Data
63/048,78907.07.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) IMMUNOSTIMULATORY ADJUVANTS
(FR) ADJUVANTS IMMUNOSTIMULATEURS
Abstract
(EN) The present invention relates, in part, to vaccine compositions, adjuvants, chimeric proteins, or chimeric protein complexes and their use as vaccines or therapeutic agents. The present invention further relates to methods of vaccination or treatment of various diseases.
(FR) La présente invention concerne, en partie, des compositions vaccinales, des adjuvants, des protéines chimères ou des complexes de protéines chimères et leur utilisation en tant que vaccins ou qu'agents thérapeutiques. La présente invention concerne également des méthodes de vaccination ou de traitement de diverses maladies.
Latest bibliographic data on file with the International Bureau